Geode Capital Management, LLC I Bio, Inc. Transaction History

Geode Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $363,603 - $727,206	-1,580,884 Reduced 43.89%	2,021,363 $533,000
Q1 2022 May 13, 2022	SELL	$0.3 - $0.61 $50,795 - $103,283	-169,318 Reduced 4.49%	3,602,247 $1.54 Million
Q4 2021 Feb 11, 2022	SELL	$0.55 - $1.04 $181,172 - $342,580	-329,404 Reduced 8.03%	3,771,565 $2.07 Million
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $559,981 - $802,991	528,284 Added 14.79%	4,100,969 $4.35 Million
Q2 2021 Aug 13, 2021	BUY	$1.22 - $1.65 $271,003 - $366,521	222,134 Added 6.63%	3,572,685 $5.39 Million
Q1 2021 May 12, 2021	BUY	$1.18 - $2.62 $1.04 Million - $2.31 Million	879,791 Added 35.61%	3,350,551 $5.16 Million
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.24 $1.02 Million - $2.18 Million	972,414 Added 64.9%	2,470,760 $2.59 Million
Q3 2020 Nov 13, 2020	BUY	$1.7 - $6.41 $1.35 Million - $5.1 Million	795,597 Added 113.21%	1,498,346 $3.04 Million
Q2 2020 Aug 13, 2020	BUY	$0.87 - $2.46 $328,814 - $929,752	377,948 Added 116.36%	702,749 $1.56 Million
Q1 2020 May 14, 2020	BUY	$0.22 - $2.45 $63,917 - $711,810	290,535 Added 847.88%	324,801 $344,000
Q2 2018 Aug 14, 2018	BUY	$0.83 - $2.1 $28,440 - $71,958	34,266 New	34,266 $30,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.